Literature DB >> 15914859

Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants.

G F Rimmelzwaan1, E G M Berkhoff1, N J Nieuwkoop1, D J Smith2, R A M Fouchier1, A D M E Osterhaus1.   

Abstract

Amino acid substitutions have been identified in the influenza A virus nucleoprotein that are associated with escape from recognition by virus-specific cytotoxic T lymphocytes (CTLs). One of these is the arginine-to-glycine substitution at position 384 (R384G). This substitution alone, however, is detrimental to viral fitness, which is overcome in part by the functionally compensating co-mutation E375G. Here, the effect on viral fitness of four other co-mutations associated with R384G was investigated by using plasmid-driven rescue of mutant viruses. Whilst none of these alternative co-mutations alone compensated functionally for the detrimental effect of the R384G substitution, the M239V substitution improved viral fitness of viruses containing 375G and 384R. The nucleoprotein displays unexpected flexibility to overcome functional constraints imposed by CTL epitope sequences, allowing influenza viruses to escape from specific CTLs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914859     DOI: 10.1099/vir.0.80867-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  A statistical phylogeography of influenza A H5N1.

Authors:  Robert G Wallace; Hoangminh Hodac; Richard H Lathrop; Walter M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

2.  Management of drug resistance in the population: influenza as a case study.

Authors:  Seyed M Moghadas
Journal:  Proc Biol Sci       Date:  2008-05-22       Impact factor: 5.349

3.  Can treatment increase the epidemic size?

Authors:  Yanyu Xiao; Fred Brauer; Seyed M Moghadas
Journal:  J Math Biol       Date:  2015-04-30       Impact factor: 2.259

4.  The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.

Authors:  Adrianus C M Boon; Gerrie de Mutsert; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Phenotypic differences in viral immune escape explained by linking within-host dynamics to host-population immunity.

Authors:  K M Pepin; I Volkov; J R Banavar; C O Wilke; B T Grenfell
Journal:  J Theor Biol       Date:  2010-06-04       Impact factor: 2.691

6.  Optimal viral immune surveillance evasion strategies.

Authors:  Alexandra Agranovich; Tal Vider-Shalit; Yoram Louzoun
Journal:  Theor Popul Biol       Date:  2011-09-02       Impact factor: 1.570

7.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution.

Authors:  Xiangjun Du; Zhuo Wang; Aiping Wu; Lin Song; Yang Cao; Haiying Hang; Taijiao Jiang
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

9.  Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.

Authors:  Rongyuan Gao; Chithra C Sreenivasan; Zizhang Sheng; Ben M Hause; Bin Zhou; David E Wentworth; Travis Clement; Dana Rausch; Colin Brunick; Jane Christopher-Hennings; Hua Wu; Christoph L Bausch; Eddie J Sullivan; Adam D Hoppe; Victor C Huber; Dan Wang; Feng Li
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

10.  Clonal interference in the evolution of influenza.

Authors:  Natalja Strelkowa; Michael Lässig
Journal:  Genetics       Date:  2012-07-30       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.